Skip to main content
Clinical Trials/JPRN-C000000246
JPRN-C000000246
Completed
Phase 1

Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I study - Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer – phase I study(MMTG study)

Multi-modality therapy for gastric cancer study group0 sites6 target enrollmentSeptember 22, 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
unresectable, locally recurrent or remnant gastric cancer
Sponsor
Multi-modality therapy for gastric cancer study group
Enrollment
6
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2005
End Date
July 1, 2007
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Multi-modality therapy for gastric cancer study group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Local tumor is not identified by computerized tomography (CT), endoscope or gastrointestinal examination 2\)Other severe medical conditions 3\)Patients need treatments for bowel obstruction or bleeding 4\)Obvious infection or acute inflammatory condition 5\)Allergy to drugs containing Cremophor EL (including cyclosporin) 6\)Brain metastases with clinical symptom 7\)Women who is pregnant, lactating or have the possibility of pregnancy 8\)Patients who is judged inappropriate by lead principal investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials